Showing posts with label Management. Show all posts
Showing posts with label Management. Show all posts

Saturday, September 28, 2013

0 The health economic impact of disease management programs for COPD: a systematic literature review and meta-analysis

Open Access


Research article


The health economic impact of disease management programs for COPD: a systematic literature review and meta-analysis



Melinde RS Boland, Apostolos Tsiachristas, Annemarije L Kruis, Niels H Chavannes and Maureen PMH Rutten-van Mölken










For all author emails, please log on.








BMC Pulmonary Medicine 2013, 13:40 doi:10.1186/1471-2466-13-40

Published: 3 July 2013





Abstract (provisional)


Background


There is insufficient evidence of the cost-effectiveness of Chronic Obstructive Pulmonary Disease (COPD) Disease Management (COPD-DM) programs. The aim of this review is to evaluate the economic impact of COPD-DM programs and investigate the relation between the impact on healthcare costs and health outcomes. We also investigated the impact of patient-, intervention, and study-characteristics.

Methods


We conducted a systematic literature review to identify cost-effectiveness studies of COPD-DM. Where feasible, results were pooled using random-effects meta-analysis and explorative subgroup analyses were performed.

Results


Sixteen papers describing 11 studies were included (7 randomized control trials (RCT), 2 pre-post, 2 case–control). Meta-analysis showed that COPD-DM led to hospitalization savings of [euro sign]1060 (95% CI: [euro sign]2040 to [euro sign]80) per patient per year and savings in total healthcare utilization of [euro sign]898 (95% CI: [euro sign]1566 to [euro sign]231) (excl. operating costs). In these health economic studies small but positive results on health outcomes were found, such as the St Georges Respiratory Questionnaire (SGRQ) score, which decreased with 1.7 points (95% CI: 0.5-2.9). There was great variability in DM interventions-, study- and patient-characteristics. There were indications that DM showed greater savings in studies with: severe COPD patients, patients with a history of exacerbations, RCT study design, high methodological quality, few different professions involved in the program, and study setting outside Europe.

Conclusions


COPD-DM programs were found to have favourable effects on both health outcomes and costs, but there is considerable heterogeneity depending on patient-, intervention-, and study-characteristics.






The complete article is available as a provisional PDF. The fully formatted PDF and HTML versions are in production.



Wednesday, September 25, 2013

0 The acute and long-term management of anaphylaxis: protocol for a systematic review

Open AccessStudy protocol

The acute and long-term management of anaphylaxis: protocol for a systematic review



Sangeeta Dhami, Sukhmeet S Panesar, Tamara Rader, Antonella Muraro, Graham Roberts, Margitta Worm and Aziz Sheikh










For all author emails, please log on.








Clinical and Translational Allergy 2013, 3:14 doi:10.1186/2045-7022-3-14

Published: 10 April 2013







Abstract (provisional)


Background


The European Academy of Allergy and Clinical Immunology is in the process of developing its Guideline for Food Allergy and Anaphylaxis, and this systematic review is one of seven inter-linked evidence syntheses that are being undertaken in order to provide a state-of-the-art synopsis of the current evidence base in relation to epidemiology, prevention, diagnosis and clinical management and impact on quality of life, which will be used to inform clinical recommendations.

The aims of this systematic review will be to assess the effectiveness of interventions for the acute management of anaphylaxis, and pharmacological and non-pharmacological approaches for the long-term management of anaphylaxis.

Methods


A highly sensitive search strategy has been developed, and validated study design filters will be applied to retrieve all articles pertaining to the management of anaphylaxis from electronic bibliographic databases. We will systematically review the literature on the acute management of anaphylaxis by assessing the effectiveness of epinephrine, H1-antihistamines (versus placebo), systemic glucocorticosteroids, methylxanthines or any other treatments for the emergency management of people experiencing anaphylaxis. The main interventions that have been studied in the context of long-term management are anaphylaxis management plans and allergen-specific immunotherapy.

Discussion


There is at present little in the way of robust evidence to guide decisions on the acute and/or long-term management of anaphylaxis. Given the risk of death and the considerable morbidity associated with anaphylaxis these evidence gaps need to be filled wherever possible; this systematic review will make a start in this area.




The complete article is available as a provisional PDF. The fully formatted PDF and HTML versions are in production.






Tuesday, September 24, 2013

0 Management of Insect Sting Hypersensitivity: An Update


Logo of aair








Allergy Asthma Immunol Res. 2013 May; 5(3): 129–137.

Published online 2013 February 25. doi:  10.4168/aair.2013.5.3.129




PMCID: PMC3636446





Management of Insect Sting Hypersensitivity: An Update








Abstract



Reactions to Hymenoptera insect stings are common. While most are self-limited, some induce systemic allergic reactions or anaphylaxis. Prompt recognition, diagnosis, and treatment of these reactions are important for improving quality-of-life and reducing the risk of future sting reactions. This review summarizes the current recommendations to diagnose and treat Hymenoptera sting induced allergic reactions and highlights considerations for various populations throughout the world.


Formats:




Keywords: Hymenoptera allergy, venom immunotherapy, sting-induced anaphylaxis, insect sting allergy, insect sting hypersensitivity




0 Incidence, clinical features and management of acute allergic reactions: the experience of a single, Italian Emergency Department


Eur Rev Med Pharmacol Sci 2013; 17 (1 Suppl): 39-44

Incidence, clinical features and management of acute allergic reactions: the experience of a single, Italian Emergency Department


E.C. Lauritano, A. Novi, M.C. Santoro, I. Casagranda


Emergency Department, SS. Antonio e Biagio e Cesare Arrigo Hospital, Alessandria, Italy. cristianolauritano@yahoo.it







OBJECTIVES: Few data on the incidence, aetiology, clinical features and management of patients with acute allergic reactions presenting to the Emergency Department are currently available. The aim of the study was to report the annual experience of a single Italian adult Emergency Department about anaphylaxis.

PATIENTS AND METHODS: This is a retrospective, case-based study of adult patients attending the Emergency Department in Alessandria, Italy, during the years 2009-2010. We evaluated the medical records of patients satisfying diagnostic codes involving acute allergic reactions. Incidence, demographic data, causative agents, clinical features, management and outcome were reported.

RESULTS: 390 patients with acute allergic reactions were evaluated during the year, corresponding to 0.7% of all Emergency Department visits. Causative agents were recognized in 55.1% of patients and more commonly included drugs (26.9%), insects (14.8%) and foods (8.9%). Cutaneous features were the single most common clinical presentation although two or more clinical features were frequently reported (17.7%). Anaphylaxis was diagnosed in 4.6% of patients. After therapy and a period of monitoring, 92.8% of patients were discharged directly from the Emergency Department, 7.0% were admitted and one patient died, corresponding to a fatality rate of 0.2%.

CONCLUSIONS: Acute allergic reactions are common diseases referring to our Emergency Department. In the half of cases a precipitant agent was identified and cutaneous and/or mucosal changes were often the first feature. Most patients were definitely treated and discharged but about 7.0% of patients required hospitalisation. Observation Unit and Intermediate Care Unit were essential for clinical management of these patients.

Free PDF Download




To cite this article


E.C. Lauritano, A. Novi, M.C. Santoro, I. Casagranda
Incidence, clinical features and management of acute allergic reactions: the experience of a single, Italian Emergency Department

Eur Rev Med Pharmacol Sci 
Year: 2013
Vol. 17 – N. 1 Suppl 
Pages: 39-44



0 Clinical management and outcome of refractory asthma in the UK from the British Thoracic Society Difficult Asthma Registry

Thorax 67:754-756 doi:10.1136/thoraxjnl-2012-201869


  • Chest clinic



  • Audit update



Clinical management and outcome of refractory asthma in the UK from the British Thoracic Society Difficult Asthma Registry


This article has been UnlockedFree via Creative Commons: OPEN ACCESS










  1. on behalf of the British Thoracic Society Difficult Asthma Network


+Author Affiliations




  1. 1Centre for Infection and Immunity, Queen’s University of Belfast, Belfast, UK




  2. 2Institute for Lung Health, Department of Infection, Inflammation and Immunity, University of Leicester, Leicester, UK




  3. 3Royal Brompton and Harefield NHS Foundation Trust, London, UK




  4. 4The University of Manchester (MAHSC) and University Hospital of South Manchester, UK




  5. 5Centre for Public Health, Queen’s University of Belfast, Belfast, UK





  1. Correspondence toProfessor Liam G Heaney, Centre for Infection and Immunity, Queen’s University of Belfast, Level 8, Belfast City Hospital, Lisburn Road, Belfast BT9 7AB, UK; l.heaney@qub.ac.uk




  1. Contributors LGH is the coordinator of the British Thoracic Society Difficult Asthma Registry and with JS collated and managed the data for this manuscript. CEB and AM-G and RN co-lead the British Thoracic Society Difficult Asthma Network and all have contributed equally to this manuscript.





  • Received 6 March 2012


  • Accepted 30 March 2012


  • Published Online First 11 May 2012




Abstract


Refractory asthma represents a significant unmet clinical need. Data from a national online registry audited clinical outcome in 349 adults with refractory asthma from four UK specialist centres in the British Thoracic Society Difficult Asthma Network. At follow-up, lung function improved, with a reduction in important healthcare outcomes, specifically hospital admission, unscheduled healthcare visits and rescue courses of oral steroids. The most frequent therapeutic intervention was maintenance oral corticosteroids and most steroid sparing agents (apart from omalizumab) demonstrated minimal steroid sparing benefit. A significant unmet clinical need remains in this group, specifically a requirement for therapies which reduce systemic steroid exposure.

Full Text







0 Diagnosis and Management of Asthma (ICSI Guideline)


Asthma, Diagnosis and Management of (Guideline)


Released 07/2012





ICSI has made a significant format enhancement in our scientific documents. All scientific documents (excluding Order Sets) now have “interactive” capability that allows a user to click on various links in the document and easily navigate from one area to another. For example, you can click on an algorithm box (those denoted with blue text and those that refer to other algorithm boxes) and link directly to the supporting annotation.


A tip for quickly going back and forth within the document:
Go to View, Toolbars, More Tools, Page Navigation, Previous View.
This should give you a back arrow tool that will allow you to go back and forth between views easily.


Note: The interactive links within ICSI PDF guidelines may not work on some mobile devices. However, the GoodReader App (and possibly some other “reader” applications) will allow anyone to open ICSI interactive PDF Guidelines on their mobile device and utilize most of the interactive capabilities. Scope and Target Population:
This guideline addresses the diagnosis, emergent, inpatient and outpatient management of acute and chronic asthma in all patients over five years of age who present with asthma-like symptoms or have been diagnosed with asthma.


Aims:



  1. Increase the rate of patients five years and older who have accurate assessment of asthma severity and control through the use of objective measures of lung function and symptoms.

  2. Increase the rate of patients five years and older who have written asthma action plans and timely and accurate assessment of asthma exacerbation.

  3. Increase the rate of patients five years and older who have appropriate treatment and management of asthma in inpatient care settings.

  4. Increase the rate of patients five years and older who have follow-up visits to ensure asthma control is maintained and appropriate therapy is administered following any visit for asthma or medication adjustment.


Clinical Highlights:



  • Conduct interval evaluations of asthma including medical history and physical examination, assessment of asthma triggers and allergens, measurement of pulmonary function, and consideration of consultation and/or allergy testing.

  • Assess control using objective measures and a validated asthma control tool.

  • Match therapy with asthma control.

  • Provide asthma education to patients and parents of pediatric patients. Education should include basic facts about asthma, how medications work, inhaler technique, a written action plan including home peak flow rate monitoring or a symptom diary, environmental control measures, and emphasis on the need for regular follow-up visits.


Additional Background:
This guideline closely follows the recommendations of the: National Asthma Education Program Expert Panel Report 2, Guidelines for the Diagnosis and Management of Asthma. NIH Publication No. 97-4051. U.S. Department of Health and Human Services, Public Health Service/National Institutes of Health/National Heart, Lung and Blood Institute.




Saturday, September 21, 2013

0 Ambulatory models of care for obstructive sleep apnoea: Diagnosis and management





You have free access to this content

Ambulatory models of care for obstructive sleep apnoea: Diagnosis and management





  1. Ching Li Chai-Coetzer1,2,*, 

  2. Nick A. Antic1,2, 

  3. R. Doug McEvoy1,2


Article first published online: 25 APR 2013

DOI: 10.1111/resp.12071






Respirology



Respirology



Volume 18, Issue 4, pages 605–615, May 2013









Keywords:




  • ambulatory care;

  • continuous positive airway pressure;

  • cost-effectiveness;

  • obstructive sleep apnoea;

  • polysomnography





Abstract



The high prevalence of obstructive sleep apnoea (OSA) and increasing awareness of its potential health consequences has placed significant pressure on laboratory-based sleep services leading to growing waiting lists and delays in diagnosis and treatment. Consequently, there has been increasing interest in the use of simplified, ambulatory models of care involving clinical prediction tools, portable sleep monitoring and home autotitrating continuous positive airway pressure. Researchers are also exploring the potential role for a wider range of health-care providers, including trained nurses and general practitioners, in the primary management of OSA. Recent randomized, controlled studies evaluating the clinical effectiveness of ambulatory management strategies versus traditional laboratory-based care for patients with OSA have consistently demonstrated that comparable patient outcomes can be achieved. The cost-effectiveness of these strategies is currently being debated, and further research examining the long-term economic implications of ambulatory models of care is needed.






Friday, September 20, 2013

0 Does Use of Inhaled Corticosteroid for Management of Asthma in Children Make Them Shorter Adults?



Logo of ped

Pediatric Allergy, Immunology, and Pulmonology











Pediatr Allergy Immunol Pulmonol. 2013 June; 26(2): 99–101.





PMCID: PMC3678560





Does Use of Inhaled Corticosteroid for Management of Asthma in Children Make Them Shorter Adults?



Hengameh H. Raissy, PharmDcorresponding author and Kathryn Blake, PharmD, BCPS, FCCP







Abstract



The purpose of this review is to discuss the effect of daily inhaled corticosteroids (ICSs) on the height of children with asthma. The effect of ICSs on growth and height is dependent on the dose and the therapeutic index of the ICS; however, the effect on final adult height was not clear until recently. New data suggest that if growth suppression occurs with the use of ICSs in children, it is sustained, but not cumulative over the years. The observed reduction in the final adult height is small and does not outweigh the benefits of ICSs, and the growth effect may be minimized by use of newer ICSs and other approaches for management of asthma in children with mild to moderate asthma.







Formats: